Published in TB and Outbreaks Week, September 16th, 2008
"Treatment with RB6-8C5 monoclonal antibody reduced local inflammation...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.